Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep) in California
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in California
| Provider | Medicare | Services |
|---|---|---|
| Yip, Peter M.D. | $16.14 | 191 |
| Nikjoo, Rabin M.D. | $16.20 | 180 |
| Sabin, Alisa M.D. | $16.13 | 169 |
| Georgies, Rami M.D. | $16.20 | 147 |
| Ellis, Eric M.D. | $15.75 | 136 |
| Yoo, Jae MD | $16.20 | 133 |
| Doonan, Bryan MD | $16.20 | 113 |
| Pham, Trieu M.D. | $16.20 | 101 |
| Pekarovics, Susan M.D. | $16.20 | 99 |
| Dominguez, Gilbert M.D. | $15.89 | 91 |
California Pricing in Context
In California, CPT code 87880 (Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep)) carries an average Medicare payment of $16.09 — 0% above the national benchmark of $16.04. 5.3K providers across the state submitted claims for this procedure in 2023, performing 33.0K total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in California is $48.66, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in California lands near $38.62, with self-pay cash prices typically around $25.45. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep) cost in California?
The average Medicare payment for Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep) in California is $16.09, which is 0% above the national average of $16.04. Providers in CA typically bill $48.66 for this procedure.
What does Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep) cost with insurance in California?
With commercial insurance in California, Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep) costs an estimated $38.62. Without insurance, the estimated cash price is $25.45. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep) in California?
5.3K providers in California billed Medicare for Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep) in 2023, performing 33.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep) cheaper in California than the national average?
No — Detection Test By Immunoassay With Direct Visual Observation For Streptococcus, Group A (strep) costs 0% above the national average in California. The state average Medicare payment is $16.09 compared to $16.04 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.